Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: The 14th signing for this quarter.PAT.

I thought that we would see this license in this quarter only because I interpreted their recognition of rev./sales when the contract is signed...? If they are interpreting revs/sales as when the cash is received then we may see a number different than our expections in April, if payment is delayed till after the quarter for some reason.

Corrections welcomed.

"Revenue from our technology license agreements is generally recognized at the time we enter into a contract and provide our customer with the licensed technology. We believe that this is the point at which we have performed all of our obligations under the agreement; however, this remains a highly interpretive area of accounting and future license agreements may result in a different method of revenue recognition. Fees for maintenance or support of our licenses are recorded on a straight-line basis over the underlying period of performance."


Feb 25, 2008 05:52AM
Share
New Message
Please login to post a reply